BridgeMD
New treatment option for Endometrial Cancer
Official title Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer
ClinicalTrials.gov ID: NCT06656949
What this study is testing
- What it's testing
- The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80, women only
You may be able to join if
- 1.Age \>18 and \<80 years old
- 2\. The pathological diagnosis was epithelial ovarian cancer
- 3.Survival time is expected to exceed 3 months
- 4.Signed consent form
You likely can't join if
- 1\. Patients with myocardial infarction or stroke, or unstable angina pectoris or decompensated heart function
- 2.Patients with a history of exhaustion or deep vein thrombosis;
- 3\. Liver insufficiency (transaminase \>2.5 times the upper limit of the standard);
- 4\. Renal insufficiency (serum muscle liver \>2 times the standard upper limit);
- 5\. Pregnancy and perinatal patients;
- 6\. History of major organ transplantation and immune disease;
See the full eligibility criteria
- 1.Age \>18 and \<80 years old
- 2\. The pathological diagnosis was epithelial ovarian cancer
- 3.Survival time is expected to exceed 3 months
- 4.Signed consent form
- 1\. Patients with myocardial infarction or stroke, or unstable angina pectoris or decompensated heart function
- 2.Patients with a history of exhaustion or deep vein thrombosis;
- 3\. Liver insufficiency (transaminase \>2.5 times the upper limit of the standard);
- 4\. Renal insufficiency (serum muscle liver \>2 times the standard upper limit);
- 5\. Pregnancy and perinatal patients;
- 6\. History of major organ transplantation and immune disease;
- 7\. Psychiatric condition or language barriers
- 8\. Alcohol or drug abuser (current or previous)
- 9\. Unable or unwilling to sign informed consent or comply with study requirements;
- 10\. Patients with other malignant tumors.
The study team makes the final eligibility decision.
Where it's taking place
- Jinan, Shandong, China
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jinan, Shandong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.